Gleiss Lutz advises medical devices manufacturer Integer on its acquisition of Oscor
A Gleiss Lutz team advised US company Integer, a leading medical device outsource manufacturer, on its USD 220 million acquisition of Oscor, a private medical device company headquartered in Palm Harbor, Florida.
Integer Holdings Corporation, listed on the New York Stock Exchange (NYSE:ITGR), is one of the world's largest outsource manufacturers of medical devices serving the cardiac, neuromodulation, vascular, portable medical, advanced surgical and orthopedics markets. In addition, it develops batteries for high-end niche applications in energy, military and environmental markets. The company's brands include Greatbatch Medical, Lake Region Medical and Electrochem.
Oscor designs, develops, manufactures and markets a variety of highly specialized implantable cardiac pacing leads, venous access systems and diagnostic catheters. The company has design, development and manufacturing operations in Palm Harbor, Florida, and in the Dominican Republic as well as a distribution center in Germany, employing approximately 900 employees company-wide.
The following team of Gleiss Lutz lawyers, led by Dr. Martin Viciano Gofferje (partner, M&A, Berlin), advised Integer on all aspects of German law in connection with the transaction: Dr. Christoph Meissner, Vanessa Sánchez López, Dr. Viktor Gorlow (all M&A), Dr. Enno Burk (counsel, regulatory/healthcare), Dr. Stefan Lingemann (partner), Josefine Chakrabarti, Viktoria Kothe (all employment), Dr. Jacob von Andreae (partner), Aylin Hoffs (both regulatory, Dusseldorf), Dr. Johannes Hertfelder (partner). Dr. Lukas Aberle, Rhued Gaiser (all antitrust, Stuttgart), Dr. Stefan Mayer (partner), Dr. Ocka Stumm (both tax), Konrad Discher (counsel, real estate, all Frankfurt), Simon Wegmann (data protection), Dr. Matthias Schilde (IP/IT, both Berlin).
US law firm Hodgson Russ LLP acted as lead counsel.
Gleiss Lutz had also previously advised Integer on the German law aspects of the sale of its "Advanced Surgical & Orthopedics" product lines to the MedPlast group for USD 600 million. In 2015, Gleiss Lutz advised Integer (at that time still under the name of Greatbatch) on the acquisition of its competitor, Lake Region Medical, from the private equity investors KKR and Bain Capital for approximately USD 1.7 billion.